Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Epidemiology of campylobacteriosis in Germany – insights from 10 years of surveillance

Authors: Anika Schielke, Bettina M Rosner, Klaus Stark

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Campylobacteriosis caused by Campylobacter spp. is the most common notifiable bacterial gastrointestinal disease in Germany and a major problem in many other European countries as well. In contrast to other infectious diseases, e.g., salmonellosis, the annual number of notified campylobacteriosis cases has increased in Germany and other European countries from 2001–2010.

Methods

National surveillance data from 2001 through 2010 were the basis of a detailed description of the epidemiological pattern of Campylobacter infections in Germany. Special focus was placed on geographical distribution and time trends of Campylobacter infections as well as the identification of risk groups.

Results

In total, 588,308 cases of campylobacteriosis were recorded during the observed time period. The mean annual incidence increased from 67 cases/100,000 population in 2001 to 80/100,000 population in 2010. Almost 92% of the notified Campylobacter infections were acquired in Germany. A seasonal distribution was observed with a large peak in the summer months and a small peak in January. Incidence was highest in children ≤4 years and young adults 20–29 years of age. Especially young children living in rural regions in Germany seemed to be at high risk of Campylobacter infection.

Conclusions

Campylobacter is the leading cause of bacterial gastroenteritis in Germany, and has been of rising public health concern. There is a need for enhanced prevention of Campylobacter infections and the data presented here may contribute to better target prevention measures with focus on identified risk groups such as children and young adults.
Appendix
Available only for authorised users
Literature
1.
go back to reference European Food Safety Authority, European Centre for Disease Prevention and Control: The european union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2010. EFSA Journal. 2012, 10 (3): 2597-CrossRef European Food Safety Authority, European Centre for Disease Prevention and Control: The european union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2010. EFSA Journal. 2012, 10 (3): 2597-CrossRef
2.
go back to reference Allos BM: Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis. 2001, 32 (8): 1201-6. 10.1086/319760.CrossRefPubMed Allos BM: Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis. 2001, 32 (8): 1201-6. 10.1086/319760.CrossRefPubMed
3.
go back to reference Centers for Disease Control and Prevention: Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food – 10 states, 2008. MMWR. 2009, 58: 333-337. Centers for Disease Control and Prevention: Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food – 10 states, 2008. MMWR. 2009, 58: 333-337.
4.
go back to reference Butzler JP: Campylobacter, from obscurity to celebrity. Clin Microbiol Infect. 2004, 10: 868-876. 10.1111/j.1469-0691.2004.00983.x.CrossRefPubMed Butzler JP: Campylobacter, from obscurity to celebrity. Clin Microbiol Infect. 2004, 10: 868-876. 10.1111/j.1469-0691.2004.00983.x.CrossRefPubMed
5.
go back to reference Man SM: The clinical importance of emerging campylobacter species. Nat Rev Gastroenterol Hepatol. 2011, 8 (12): 669-85. 10.1038/nrgastro.2011.191.CrossRefPubMed Man SM: The clinical importance of emerging campylobacter species. Nat Rev Gastroenterol Hepatol. 2011, 8 (12): 669-85. 10.1038/nrgastro.2011.191.CrossRefPubMed
6.
go back to reference Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM: Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis. 2011, 17 (1): 7-15.CrossRefPubMedPubMedCentral Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM: Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis. 2011, 17 (1): 7-15.CrossRefPubMedPubMedCentral
7.
go back to reference Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U: Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010, 300 (4): 205-11. 10.1016/j.ijmm.2009.07.002.CrossRefPubMed Dasti JI, Tareen AM, Lugert R, Zautner AE, Gross U: Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol. 2010, 300 (4): 205-11. 10.1016/j.ijmm.2009.07.002.CrossRefPubMed
8.
go back to reference Doorduyn Y, Van Den Brandhof WE, Van Duynhoven YT, Breukink BJ, Wagenaar JA, Van Pelt W: Risk factors for indigenous campylobacter jejuni and campylobacter coli infections in the Netherlands: a case–control study. Epidemiol Infect. 2010, 138 (10): 1391-404. 10.1017/S095026881000052X.CrossRefPubMed Doorduyn Y, Van Den Brandhof WE, Van Duynhoven YT, Breukink BJ, Wagenaar JA, Van Pelt W: Risk factors for indigenous campylobacter jejuni and campylobacter coli infections in the Netherlands: a case–control study. Epidemiol Infect. 2010, 138 (10): 1391-404. 10.1017/S095026881000052X.CrossRefPubMed
9.
go back to reference Robinson DA: Campylobacter infection. R Soc Health J. 1981, 101 (4): 138-40. 10.1177/146642408110100404.CrossRefPubMed Robinson DA: Campylobacter infection. R Soc Health J. 1981, 101 (4): 138-40. 10.1177/146642408110100404.CrossRefPubMed
11.
go back to reference Robinson DA: Infective dose of campylobacter jejuni in milk. Br Med J. 1981, 282 (6276): 1584-CrossRef Robinson DA: Infective dose of campylobacter jejuni in milk. Br Med J. 1981, 282 (6276): 1584-CrossRef
12.
go back to reference Poropatich KO, Walker CL, Black RE: Quantifying the association between campylobacter infection and guillain-barré syndrome: a systematic review. J Health Popul Nutr. 2010, 28 (6): 545-52.CrossRefPubMedPubMedCentral Poropatich KO, Walker CL, Black RE: Quantifying the association between campylobacter infection and guillain-barré syndrome: a systematic review. J Health Popul Nutr. 2010, 28 (6): 545-52.CrossRefPubMedPubMedCentral
14.
go back to reference European Centre for Disease Prevention and Control: Annual Epidemiological Report 2011. Reporting on 2009 surveillance data and 2010 epidemic intelligence data. 2011, Stockholm: ECDC European Centre for Disease Prevention and Control: Annual Epidemiological Report 2011. Reporting on 2009 surveillance data and 2010 epidemic intelligence data. 2011, Stockholm: ECDC
15.
go back to reference Ang CW, Teunis PF, Herbrink P, Keijser J, Van Duynhoven YH, Visser CE, van Pelt W: Seroepidemiological studies indicate frequent and repeated exposure to campylobacter spp. During childhood. Epidemiol Infect. 2011, 139 (9): 1361-8. 10.1017/S0950268810002359.CrossRefPubMed Ang CW, Teunis PF, Herbrink P, Keijser J, Van Duynhoven YH, Visser CE, van Pelt W: Seroepidemiological studies indicate frequent and repeated exposure to campylobacter spp. During childhood. Epidemiol Infect. 2011, 139 (9): 1361-8. 10.1017/S0950268810002359.CrossRefPubMed
16.
go back to reference Jansen A, Stark K, Kunkel J, Schreier E, Ignatius R, Liesenfeld O, Werber D, Göbel UB, Zeitz M, Schneider T: Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study. BMC Infect Dis. 2008, 8: 143-10.1186/1471-2334-8-143.CrossRefPubMedPubMedCentral Jansen A, Stark K, Kunkel J, Schreier E, Ignatius R, Liesenfeld O, Werber D, Göbel UB, Zeitz M, Schneider T: Aetiology of community-acquired, acute gastroenteritis in hospitalised adults: a prospective cohort study. BMC Infect Dis. 2008, 8: 143-10.1186/1471-2334-8-143.CrossRefPubMedPubMedCentral
17.
go back to reference Havelaar AH, van Pelt W, Ang CW, Wagenaar JA, van Putten JP, Gross U, Newell DG: Immunity to campylobacter: its role in risk assessment and epidemiology. Crit Rev Microbiol. 2009, 35 (1): 1-22. 10.1080/10408410802636017.CrossRefPubMed Havelaar AH, van Pelt W, Ang CW, Wagenaar JA, van Putten JP, Gross U, Newell DG: Immunity to campylobacter: its role in risk assessment and epidemiology. Crit Rev Microbiol. 2009, 35 (1): 1-22. 10.1080/10408410802636017.CrossRefPubMed
18.
go back to reference Federal Statistical Office: Vom Erzeuger zum Verbraucher Fleischversorgung in Deutschland Ausgabe 2008. 2008, Wiesbaden: Statistisches Bundesamt Federal Statistical Office: Vom Erzeuger zum Verbraucher Fleischversorgung in Deutschland Ausgabe 2008. 2008, Wiesbaden: Statistisches Bundesamt
19.
go back to reference Federal Institute for Risk Assessment: Erreger von Zoonosen in Deutschland im Jahr 2010. BfR-Wissenschaft. 2012 Federal Institute for Risk Assessment: Erreger von Zoonosen in Deutschland im Jahr 2010. BfR-Wissenschaft. 2012
20.
go back to reference Robert Koch Institute: Campylobacter-jejuni-Infektionen treten 2007 vermehrt auf. Epid Bull. 2007, 331-334. 36 Robert Koch Institute: Campylobacter-jejuni-Infektionen treten 2007 vermehrt auf. Epid Bull. 2007, 331-334. 36
21.
go back to reference Federal Institute for Risk Assessment: Erreger von Zoonosen in Deutschland im Jahr 2007. BfR-Wissenschaft. 2009, 05 Federal Institute for Risk Assessment: Erreger von Zoonosen in Deutschland im Jahr 2007. BfR-Wissenschaft. 2009, 05
22.
go back to reference Lal A, Hales S, French N, Baker MG: Seasonality in human zoonotic enteric diseases: a systematic review. PLoS One. 2012, 7 (4): e31883-10.1371/journal.pone.0031883.CrossRefPubMedPubMedCentral Lal A, Hales S, French N, Baker MG: Seasonality in human zoonotic enteric diseases: a systematic review. PLoS One. 2012, 7 (4): e31883-10.1371/journal.pone.0031883.CrossRefPubMedPubMedCentral
23.
go back to reference Nichols GL, Richardson JF, Sheppard SK, Lane C, Sarran C: Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ Open. 2012, 2 (4): e001179-CrossRefPubMedPubMedCentral Nichols GL, Richardson JF, Sheppard SK, Lane C, Sarran C: Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011. BMJ Open. 2012, 2 (4): e001179-CrossRefPubMedPubMedCentral
24.
go back to reference Federal Institute for Risk Assessment: Erreger von Zoonosen in Deutschland im Jahr 2008. BfR-Wissenschaft. 2010, 06 Federal Institute for Risk Assessment: Erreger von Zoonosen in Deutschland im Jahr 2008. BfR-Wissenschaft. 2010, 06
25.
go back to reference Scherer K, Bartelt E, Sommerfeld C, Hildebrandt G: Quantification of Campylobacter on the surface and in the muscle of chicken legs at retail. J Food Prot. 2006, 69 (4): 757-61.PubMed Scherer K, Bartelt E, Sommerfeld C, Hildebrandt G: Quantification of Campylobacter on the surface and in the muscle of chicken legs at retail. J Food Prot. 2006, 69 (4): 757-61.PubMed
26.
go back to reference Rosner BM, Stark K, Werber D: Epidemiology of reported Yersinia enterocolitica infections in Germany, 2001–2008. BMC Public Health. 2010, 10: 337-10.1186/1471-2458-10-337.CrossRefPubMedPubMedCentral Rosner BM, Stark K, Werber D: Epidemiology of reported Yersinia enterocolitica infections in Germany, 2001–2008. BMC Public Health. 2010, 10: 337-10.1186/1471-2458-10-337.CrossRefPubMedPubMedCentral
27.
go back to reference Werber D, Behnke SC, Fruth A, Merle R, Menzler S, Glaser S, Kreienbrock L, Prager R, Tschäpe H, Roggentin P, Bockemühl J, Ammon A: Shiga toxin-producing escherichia coli infection in Germany: different risk factors for different age groups. Am J Epidemiol. 2007, 165 (4): 425-34.CrossRefPubMed Werber D, Behnke SC, Fruth A, Merle R, Menzler S, Glaser S, Kreienbrock L, Prager R, Tschäpe H, Roggentin P, Bockemühl J, Ammon A: Shiga toxin-producing escherichia coli infection in Germany: different risk factors for different age groups. Am J Epidemiol. 2007, 165 (4): 425-34.CrossRefPubMed
28.
go back to reference Tabu C, Breiman RF, Ochieng B, Aura B, Cosmas L, Audi A, Olack B, Bigogo G, Ongus JR, Fields P, Mintz E, Burton D, Oundo J, Feikin DR: Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya, 2006–2009. PLoS One. 2012, 7 (2): e31237-10.1371/journal.pone.0031237.CrossRefPubMedPubMedCentral Tabu C, Breiman RF, Ochieng B, Aura B, Cosmas L, Audi A, Olack B, Bigogo G, Ongus JR, Fields P, Mintz E, Burton D, Oundo J, Feikin DR: Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya, 2006–2009. PLoS One. 2012, 7 (2): e31237-10.1371/journal.pone.0031237.CrossRefPubMedPubMedCentral
29.
go back to reference Gillespie IA, O’Brien SJ, Penman C, Tompkins D, Cowden J, Humphrey TJ: Demographic determinants for campylobacter infection in England and Wales: implications for future epidemiological studies. Epidemiol Infect. 2008, 136 (12): 1717-25. 10.1017/S0950268808000319.CrossRefPubMedPubMedCentral Gillespie IA, O’Brien SJ, Penman C, Tompkins D, Cowden J, Humphrey TJ: Demographic determinants for campylobacter infection in England and Wales: implications for future epidemiological studies. Epidemiol Infect. 2008, 136 (12): 1717-25. 10.1017/S0950268808000319.CrossRefPubMedPubMedCentral
30.
go back to reference Fitzenberger J, Uphoff H, Gawrich S, Hauri AM: Urban–rural differences of age- and species-specific campylobacteriosis incidence, Hesse, Germany, July 2005 - June 2006. Euro Surveill. 2010, 15 (42): 19693-PubMed Fitzenberger J, Uphoff H, Gawrich S, Hauri AM: Urban–rural differences of age- and species-specific campylobacteriosis incidence, Hesse, Germany, July 2005 - June 2006. Euro Surveill. 2010, 15 (42): 19693-PubMed
31.
go back to reference Ethelberg S, Simonsen J, Gerner-Smidt P, Olsen KE, Mølbak K: Spatial distribution and registry-based case–control analysis of campylobacter infections in Denmark, 1991–2001. Am J Epidemiol. 2005, 162 (10): 1008-15. 10.1093/aje/kwi316.CrossRefPubMed Ethelberg S, Simonsen J, Gerner-Smidt P, Olsen KE, Mølbak K: Spatial distribution and registry-based case–control analysis of campylobacter infections in Denmark, 1991–2001. Am J Epidemiol. 2005, 162 (10): 1008-15. 10.1093/aje/kwi316.CrossRefPubMed
Metadata
Title
Epidemiology of campylobacteriosis in Germany – insights from 10 years of surveillance
Authors
Anika Schielke
Bettina M Rosner
Klaus Stark
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-30

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.